These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 8305582
21. Determination of N-acetylation phenotyping in a Greek population using caffeine as a metabolic probe. Asprodini EK, Zifa E, Papageorgiou I, Benakis A. Eur J Drug Metab Pharmacokinet; 1998; 23(4):501-6. PubMed ID: 10323334 [Abstract] [Full Text] [Related]
26. Determination of caffeine and its metabolites in urine by high-performance liquid chromatography and capillary electrophoresis. Rodopoulos N, Norman A. Scand J Clin Lab Invest; 1994 Jul; 54(4):305-15. PubMed ID: 7939374 [Abstract] [Full Text] [Related]
29. A simple test for acetylator phenotype using caffeine. Grant DM, Tang BK, Kalow W. Br J Clin Pharmacol; 1984 Apr; 17(4):459-64. PubMed ID: 6721992 [Abstract] [Full Text] [Related]
31. Caffeine as a metabolic probe: validation of its use for acetylator phenotyping. Tang BK, Kadar D, Qian L, Iriah J, Yip J, Kalow W. Clin Pharmacol Ther; 1991 Jun; 49(6):648-57. PubMed ID: 2060254 [Abstract] [Full Text] [Related]
32. Development and validation of a rapid and efficient method for simultaneous determination of methylxanthines and their metabolites in urine using monolithic HPLC columns. Atia NN, York P, Clark BJ. J Sep Sci; 2009 Apr; 32(7):931-8. PubMed ID: 19266550 [Abstract] [Full Text] [Related]
33. Concordance between the deduced acetylation status generated by high-speed: real-time PCR based NAT2 genotyping of seven single nucleotide polymorphisms and human NAT2 phenotypes determined by a caffeine assay. Rihs HP, John A, Scherenberg M, Seidel A, Brüning T. Clin Chim Acta; 2007 Feb; 376(1-2):240-3. PubMed ID: 17011540 [Abstract] [Full Text] [Related]
34. Measurement of caffeine and five of the major metabolites in urine by high-performance liquid chromatography/tandem mass spectrometry. Weimann A, Sabroe M, Poulsen HE. J Mass Spectrom; 2005 Mar; 40(3):307-16. PubMed ID: 15685651 [Abstract] [Full Text] [Related]
37. Extractionless method for the determination of urinary caffeine metabolites using high-performance liquid chromatography coupled with tandem mass spectrometry. Schneider H, Ma L, Glatt H. J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jun 15; 789(2):227-37. PubMed ID: 12742114 [Abstract] [Full Text] [Related]
38. Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells. Frederickson SM, Messing EM, Reznikoff CA, Swaminathan S. Cancer Epidemiol Biomarkers Prev; 1994 Jun 15; 3(1):25-32. PubMed ID: 8118381 [Abstract] [Full Text] [Related]
39. Development and validation of a reversed-phase HPLC method for CYP1A2 phenotyping by use of a caffeine metabolite ratio in saliva. Begas E, Kouvaras E, Tsakalof AK, Bounitsi M, Asprodini EK. Biomed Chromatogr; 2015 Nov 15; 29(11):1657-63. PubMed ID: 25891161 [Abstract] [Full Text] [Related]
40. Antipyrine, coumarin and glipizide affect n-acetylation measured by caffeine test. Klebovich I, Rautio A, Salonpää P, Arvela P, Pelkonen O, Sotaniemi EA. Biomed Pharmacother; 1995 Nov 15; 49(5):225-7. PubMed ID: 7579000 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]